ES8201316A1 - Procedimiento de preparar agentes de utilidad clinica a par-tir de substancias solubles en lipoides - Google Patents

Procedimiento de preparar agentes de utilidad clinica a par-tir de substancias solubles en lipoides

Info

Publication number
ES8201316A1
ES8201316A1 ES80498048A ES498048A ES8201316A1 ES 8201316 A1 ES8201316 A1 ES 8201316A1 ES 80498048 A ES80498048 A ES 80498048A ES 498048 A ES498048 A ES 498048A ES 8201316 A1 ES8201316 A1 ES 8201316A1
Authority
ES
Spain
Prior art keywords
biologically active
lipoid
preparing
active particles
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES80498048A
Other languages
English (en)
Other versions
ES498048A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HUMAN OLTOANYAGTERMELO
Original Assignee
HUMAN OLTOANYAGTERMELO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUMAN OLTOANYAGTERMELO filed Critical HUMAN OLTOANYAGTERMELO
Publication of ES498048A0 publication Critical patent/ES498048A0/es
Publication of ES8201316A1 publication Critical patent/ES8201316A1/es
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586—Liposomes, microcapsules or cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO DE PREPARAR AGENTES DE UTILIDAD CLINICA A PARTIR DE SUSTANCIAS SOLUBLES EN LIPOIDES. SE MEZCLA UNA SUSTANCI FORMADORA DE PARTICULAS DE LIPOIDES QUE CONTIENE UN AGENTE DE ACTIVIDAD SUPERFICIAL DISUELTO EN ALCOHOL, O CUALQUIER OTRO DISOLVENTE ORGANICO, CON UNA DISOLUCION DE UNA SUSTANCIA BIOLOGICAMENTE ACTIVA EN AGUA O UNA DISOLUCION CON UN PH DE 2 A 10, EN UNA RELACION DE VOLUMEN DE 1: 1000 A 9: 1, AGITANDO LA MEZCLA DE REACCION DURANTE UN MINUTO, AL MENOS, Y DEJANDOLO REPOSAR DURANTE SIETE DIAS, PARA LUEGO SEPARAR LAS PARTICULAS PRECIPITADAS. TAMBIEN SE PUEDE MEZCLAR CON UNA SOLUCION ELECTROLITICA ACUOSA, SEPARANDO LAS PARTICULAS PRECIPITADAS Y SUSPENDERLAS EN AGUA O EN UNA DISOLUCION ELECTROLITICA ACUOSA CON AGITACION O SIN ELLA. SE UTILIZA PARA PREPARAR SISTEMAS PARA EXAMENES DE INMUNODIAGNOSIS <IN VITRO>, COMO DIAGNOSTICO DE UNA DETERMINACION CUANTITATIVA DE ARTRITIS REUMATOIDE.
ES80498048A 1979-12-27 1980-12-22 Procedimiento de preparar agentes de utilidad clinica a par-tir de substancias solubles en lipoides Expired ES8201316A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79HU299A HU184141B (en) 1979-12-27 1979-12-27 Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof

Publications (2)

Publication Number Publication Date
ES498048A0 ES498048A0 (es) 1981-12-16
ES8201316A1 true ES8201316A1 (es) 1981-12-16

Family

ID=10997378

Family Applications (1)

Application Number Title Priority Date Filing Date
ES80498048A Expired ES8201316A1 (es) 1979-12-27 1980-12-22 Procedimiento de preparar agentes de utilidad clinica a par-tir de substancias solubles en lipoides

Country Status (21)

Country Link
US (1) US4396630A (es)
JP (1) JPS57112334A (es)
BE (1) BE886884A (es)
CA (1) CA1165237A (es)
CH (1) CH655246A5 (es)
CS (1) CS241478B2 (es)
DD (1) DD158738A5 (es)
DE (1) DE3048815A1 (es)
DK (1) DK160288C (es)
ES (1) ES8201316A1 (es)
FR (1) FR2472386B1 (es)
GB (1) GB2066203B (es)
HU (1) HU184141B (es)
IT (1) IT1150073B (es)
NL (1) NL8007041A (es)
PL (1) PL228755A1 (es)
PT (1) PT72261B (es)
RO (1) RO81371A (es)
SE (1) SE453537B (es)
SU (1) SU1487802A3 (es)
YU (1) YU44413B (es)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4598051A (en) * 1980-03-12 1986-07-01 The Regents Of The University Of California Liposome conjugates and diagnostic methods therewith
US4806466A (en) * 1981-10-29 1989-02-21 The Regents Of The University Of California Cell agglutination reagent comprising conjugates of antibody covalently bound to liposomes
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
DD247570A3 (de) * 1983-01-14 1987-07-15 Univ Berlin Humboldt Vesikulaeres trenn-, fuell- und traegermaterial
US4515736A (en) * 1983-05-12 1985-05-07 The Regents Of The University Of California Method for encapsulating materials into liposomes
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
US6090406A (en) * 1984-04-12 2000-07-18 The Liposome Company, Inc. Potentiation of immune responses with liposomal adjuvants
US5916588A (en) * 1984-04-12 1999-06-29 The Liposome Company, Inc. Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
GB2160312B (en) * 1984-04-13 1987-09-16 South African Inventions Adjuvant for immunisation
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
US4619904A (en) * 1984-10-29 1986-10-28 General Electric Company Agglutinating immunoassay using protein-coated liquid droplets
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
ATE68686T1 (de) * 1985-10-31 1991-11-15 Kv Pharm Co System zum freigeben von stoffen in der vagina.
US5266329A (en) * 1985-10-31 1993-11-30 Kv Pharmaceutical Company Vaginal delivery system
US4790987A (en) * 1985-11-15 1988-12-13 Research Corporation Viral glycoprotein subunit vaccine
CA1338736C (fr) * 1986-12-05 1996-11-26 Roger Baurain Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation
US5688519A (en) * 1987-04-06 1997-11-18 Leonard; Robert J. Flash-flow fused medicinal implants
US4748024A (en) * 1987-04-06 1988-05-31 Endocon, Inc. Flash flow fused medicinal implants
WO1990001947A1 (en) * 1988-08-25 1990-03-08 The Liposome Company, Inc. Affinity associated vaccine
ATE118096T1 (de) * 1988-12-22 1995-02-15 Baxter Diagnostics Inc Lipohaptene und verwendung trägergebundener lipohaptene im immuntest.
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
JPH07113641B2 (ja) * 1989-11-17 1995-12-06 積水化学工業株式会社 梅毒診断試薬の製造方法
NL9000207A (es) * 1990-01-29 1991-08-16 Duphar Int Res
DE69131709T2 (de) * 1990-06-29 2000-05-25 Chiron Corp., Emeryville Liposomen enthaltende impfstoffzusammensetzungen
US5709879A (en) * 1990-06-29 1998-01-20 Chiron Corporation Vaccine compositions containing liposomes
IE912535A1 (en) * 1990-07-27 1992-01-29 Res Dev Foundation Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens
WO1992004887A1 (en) * 1990-09-25 1992-04-02 Kyowa Hakko Kogyo Co., Ltd. Induction of cytotoxic t cell
US6048531A (en) * 1991-04-15 2000-04-11 Albany Medical College Immunogenic composites capable of stimulating production of anti-peptide antibodies, pharmaceutical compositions employing these composites and methods of selectively inducing production of anti-peptide antibodies
US5336507A (en) * 1992-12-11 1994-08-09 Sterling Winthrop Inc. Use of charged phospholipids to reduce nanoparticle aggregation
GB9320668D0 (en) * 1993-10-07 1993-11-24 Secr Defence Liposomes containing particulare materials
AUPM500494A0 (en) * 1994-04-12 1994-05-05 Minister For Agriculture & Rural Affairs For The State Of New South Wales, The Composition for use in increasing mucosal immunity
CA2427467C (en) * 2000-11-09 2010-01-12 Neopharm, Inc. Sn-38 lipid complexes and methods of use
WO2003030864A1 (en) * 2001-05-29 2003-04-17 Neopharm, Inc. Liposomal formulation of irinotecan
WO2003075890A1 (en) * 2002-03-05 2003-09-18 Transave, Inc. Methods for entrapment of bioactive agent in a liposome or lipid complex
AU2003296897A1 (en) * 2002-08-20 2004-05-04 Neopharm, Inc. Pharmaceutical formulations of camptothecine derivatives
US20060030578A1 (en) * 2002-08-20 2006-02-09 Neopharm, Inc. Pharmaceutically active lipid based formulation of irinotecan
EP2823820B1 (en) * 2002-10-29 2018-06-06 Insmed Incorporated Liposomes comprising an aminoglycoside for the treatment of pulmonary infections
US7718189B2 (en) * 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
KR100651728B1 (ko) * 2004-11-10 2006-12-06 한국전자통신연구원 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
WO2006090816A1 (ja) * 2005-02-25 2006-08-31 Mie University リポソームワクチンの作製法
AU2006322076C1 (en) 2005-12-08 2013-11-14 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
KR102092361B1 (ko) 2012-05-21 2020-03-23 인스메드 인코포레이티드 폐 감염을 치료하기 위한 시스템
MX2015006681A (es) 2012-11-29 2016-04-06 Insmed Inc Formulaciones de vancomicina estabilizadas.
ES2981634T3 (es) 2014-05-15 2024-10-09 Insmed Incorporated Métodos para tratar infecciones micobacterianas pulmonares no tuberculosas
EP3773505A4 (en) 2018-03-30 2021-12-22 Insmed Incorporated PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265629A (en) * 1958-12-22 1966-08-09 Ncr Co Coating by phase separation
DE2249552A1 (de) * 1971-10-12 1973-05-30 Inchema S A Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
JPS5126213A (ja) * 1974-08-21 1976-03-04 Tanabe Seiyaku Co Johoseibiryushiseizaino seiho
GB1564500A (en) * 1975-09-29 1980-04-10 Wellcome Found Biological preparations
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
IT1110989B (it) * 1979-01-19 1986-01-13 Erba Farmitalia Forme farmaceutiche costitutite da liposomi e procedimenti relativi
FR2416008A1 (fr) * 1978-02-02 1979-08-31 Oreal Lyophilisats de liposomes
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
JPS55118415A (en) * 1979-02-28 1980-09-11 Pii Papahadojiyopo Dometoriosu Method of encapsulating biologically active substance in lipoid cell

Also Published As

Publication number Publication date
YU329080A (en) 1984-04-30
RO81371A (ro) 1984-04-02
FR2472386B1 (es) 1985-08-23
DK160288C (da) 1991-08-05
ES498048A0 (es) 1981-12-16
PL228755A1 (es) 1982-02-15
NL8007041A (nl) 1981-07-16
PT72261A (en) 1981-01-01
DE3048815A1 (de) 1981-09-10
DD158738A5 (de) 1983-02-02
US4396630A (en) 1983-08-02
CS924680A2 (en) 1985-07-16
CS241478B2 (en) 1986-03-13
BE886884A (fr) 1981-06-29
CA1165237A (en) 1984-04-10
YU44413B (en) 1990-08-31
DK160288B (da) 1991-02-25
JPH0314814B2 (es) 1991-02-27
CH655246A5 (de) 1986-04-15
IT8026950A0 (it) 1980-12-24
JPS57112334A (en) 1982-07-13
GB2066203A (en) 1981-07-08
FR2472386A1 (es) 1981-07-03
SE8009068L (sv) 1981-06-28
DK552280A (da) 1981-06-28
GB2066203B (en) 1984-01-11
SU1487802A3 (ru) 1989-06-15
PT72261B (en) 1981-11-05
RO81371B (ro) 1983-11-02
HU184141B (en) 1984-07-30
IT1150073B (it) 1986-12-10
SE453537B (sv) 1988-02-08

Similar Documents

Publication Publication Date Title
ES8201316A1 (es) Procedimiento de preparar agentes de utilidad clinica a par-tir de substancias solubles en lipoides
AU587525B2 (en) Indolizine derivatives, process for preparing them and the compositions containing them
EP0326618A4 (en) MEDICAL COMPOSITION, WHICH CONTAINS ALBUMIN AS A CARRIER, AND METHOD FOR THE PRODUCTION THEREOF.
PT83509A (en) Process for the preparation of pharmaceutical compositions with controlled release of metoprolol
PH21386A (en) Platinum-diamine complexes, their pharmaceutical compositions and process for the preparation thereof
DE3060777D1 (en) Drug composition based on plants and process for its preparation
AU646112B2 (en) N,O-sulphated heparosans, process for preparing them and pharmaceutical compositions containing them
AU5642294A (en) Bacteriocidal gas composition and process for preparing the same
HUT36991A (en) Herbicide compositions containing 1-aryl-4-substituted-1,4-dihydro-5h-tetrazol-5-one /or-thione/ derivatives and process for preparing the active substances
HUT42292A (en) Insecticidal compositions comprising fluorbenzyl esters as active substance and process for preparing the active substances
EP0175667A3 (en) Macrophage-activating composition and a process for its manufacture
HUT36345A (en) Herbicide compositions containing cyano-pyrazole derivatives as active substances and process for preparing the active substances
AU6398680A (en) Substituted carboxylic ceto-acids, process for the preparation thereof, use thereof and medicinal compositions containing them
IL56522A0 (en) Insecticidal esters, process for preparing them and the insecticidal compositions containing them
ES477562A1 (es) Procedimiento para preparar derivados de alcanolamina.
DE3169602D1 (en) 2-pyridinecarboxamide derivative, process for preparing same and pharmaceutical composition, useful as an anti-allergic agent
HUT37857A (en) Insectide compositions containing cyclodextrin inclusion complex as active substance and process for preparing the active substances
GB2050833B (en) Pharmaceutical compositions and process for the preparation thereof
AU552567B2 (en) Oligopeptides with specific inhibiting properties of collageninduced aggregation, process for preparing the same and pharmaceutical compositions containing them
AU540216B2 (en) Nicotinamide derivative, process for preparing the same and pharmaceutical composition containing the same
ES473316A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas.
DE3479656D1 (en) Rhodanine derivative, process for preparing the same and pharmaceutical composition containing the same
DE3160797D1 (en) 11-alpha-amino androstanes, pharmaceutical compositions containing them and processes for their preparation
DE3368046D1 (en) Biphenylylpropionic acid derivative, process for preparing the same and pharmaceutical composition containing the same
EP0091598A3 (en) Fluoro-ethoxyphenyl-(di)-thiophosphoric-acid esters, process for their preparation and their use as pesticides